These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32266816)
1. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4. Nie FR; Li QX; Wei HF; Ma Y Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816 [TBL] [Abstract][Full Text] [Related]
2. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p. Li Y; Qin J; He Z; Cui G; Zhang K; Wu B Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227 [TBL] [Abstract][Full Text] [Related]
4. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818 [TBL] [Abstract][Full Text] [Related]
6. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929 [TBL] [Abstract][Full Text] [Related]
8. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
10. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway. Du Y; Zhu J; Chu BF; Yang YP; Zhang SL Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway. Bi CL; Zhang YQ; Li B; Guo M; Fu YL J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2. Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195 [TBL] [Abstract][Full Text] [Related]
14. MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD. Zhu J; Zhang Q; Jin XY; Cai JB; Chen X; Shi WB; Pang WY; Guo GL; Yang LJ Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2856-2862. PubMed ID: 31002136 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
16. MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation. Chen G; Gao Y; Wang G; Dai G; Tong L J Cell Biochem; 2020 Jun; 121(5-6):3325-3332. PubMed ID: 31907977 [TBL] [Abstract][Full Text] [Related]
17. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway. Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma. Wang Z; Zhang H; Zhang P; Dong W; He L Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma. Zhang S; Wang Q; Li D; Huang B; Hou X; Wang D Mol Med Rep; 2019 Feb; 19(2):1403-1409. PubMed ID: 30569166 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634 [No Abstract] [Full Text] [Related] [Next] [New Search]